Consistent with the in vitro result, the knockdown of SLC39A1 attenuated tumour progression, including reduced tumour weight, tumour‐to‐body weight ratio and tumour volume, while body weight was barely changed (Figure 1J). Here, SLC39A1 is linked to neoplasm.